Review article: Dietary fibre-microbiota interactions

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 2, 2015, Pages 158-179

  Simpson, H L ^a   Campbell, B J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT;

AGRARIAN DIET; ARTICLE; BACTEROIDES; CARBOHYDRATE INTAKE; COLON DISEASE; CROHN DISEASE; DIET; DIET RESTRICTION; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; ENTERIC FEEDING; ENTERITIS; EPIDEMIOLOGICAL DATA; FEEDING BEHAVIOR; FIRMICUTES; GENETIC PROCEDURES; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LONG TERM CARE; METABOLOME; METAGENOMICS; METAPROTEOMICS; METATRANSCRIPTOMICS; MICROBIAL DIVERSITY; NONHUMAN; NUTRITIONAL VALUE; PREVOTELLA; PRIORITY JOURNAL; PROTEOBACTERIA; PYROSEQUENCING; RISK FACTOR; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; WESTERN DIET; ADMINISTRATION AND DOSAGE; ANIMAL; BIFIDOBACTERIUM; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; PHYSIOLOGY;

ANIMALS; BACTEROIDES; BIFIDOBACTERIUM; DIET; DIETARY FIBER; FIRMICUTES; FOOD HABITS; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; METABOLOME;

EID: 84931575689     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13248     Document Type: Article

References (125)

1. Hold GL,. The gut microbiota, dietary extremes and exercise. Gut 2014; 63: 1838-9.
2. Jeffery IB, O'Toole PW,. Diet-microbiota interactions and their implications for healthy living. Nutrients 2013; 5: 234-52.
3. Weinstock GM,. Genomic approaches to studying the human microbiota. Nature 2012; 489: 250-6.
4. Morgan XC, Huttenhower C,. Chapter 12: human microbiome analysis. PLoS Comput Biol 2012; 8: e1002808.
5. Fritz JV, Desai MS, Shah P, Schneider JG, Wilmes P,. From meta-omics to causality: experimental models for human microbiome research. Microbiome 2013; 1: 14.
6. Segata N, Boernigen D, Tickle TL, Morgan XC, Garrett WS, Huttenhower C,. Computational meta'omics for microbial community studies. Mol Syst Biol 2013; 9: 666.
7. Morgan XC, Huttenhower C,. Meta'omic analytic techniques for studying the intestinal microbiome. Gastroenterology 2014; 146: 1437-48.
8. Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS,. Application of metagenomics in the human gut microbiome. World J Gastroenterol 2015; 21: 803-14.
9. Gill SR, Pop M, Deboy RT, et al,. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312: 1355-9.
10. Qin J, Li R, Raes J, et al,. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464: 59-65.
11. Ramakrishna BS,. Role of the gut microbiota in human nutrition and metabolism. J Gastroenterol Hepatol 2013; 28 (Suppl. 4): 9-17.
12. Belkaid Y, Hand TW,. Role of the microbiota in immunity and inflammation. Cell 2014; 157: 121-41.
13. Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I,. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? World J Gastroenterol 2014; 20: 1192-210.
14. Cox AJ, West NP, Cripps AW,. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol 2014; 3: 207-15
15. Tilg H, Moschen AR,. Microbiota and diabetes: an evolving relationship. Gut 2014; 63: 1513-21.
16. Ardissone AN, de la Cruz DM, Davis-Richardson AG, et al,. Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS ONE 2014; 9: e90784.
17. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J,. The placenta harbors a unique microbiome. Sci Transl Med 2014; 6: 237ra65.
18. Dominguez-Bello MG, Costello EK, Contreras M, et al,. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107: 11971-5.
19. Koenig JE, Spor A, Scalfone N, et al,. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011; 108: 4578-85.
20. Albenberg LG, Wu GD,. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 2014; 146: 1564-72.
21. Faith JJ, Guruge JL, Charbonneau M, et al,. The long-term stability of the human gut microbiota. Science 2013; 341: 1237439.
22. Tiihonen K, Ouwehand AC, Rautonen N,. Human intestinal microbiota and healthy ageing. Ageing Res Rev 2010; 9: 107-16.
23. Tap J, Mondot S, Levenez F, et al,. Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 2009; 11: 2574-84.
24. Turnbaugh PJ, Hamady M, Yatsunenko T, et al,. A core gut microbiome in obese and lean twins. Nature 2009; 457: 480-4.
25. Sekelja M, Berget I, Naes T, Rudi K,. Unveiling an abundant core microbiota in the human adult colon by a phylogroup-independent searching approach. ISME J 2011; 5: 519-31.
26. Walker AW, Ince J, Duncan SH, et al,. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011; 5: 220-30.
27. Arumugam M, Raes J, Pelletier E, et al,. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-80.
28. Koren O, Knights D, Gonzalez A, et al,. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol 2013; 9: e1002863.
29. Arumugam M, Raes J, Pelletier E, et al,. Addendum: enterotypes of the human gut microbiome. Nature 2014; 506: 516.
30. Knights D, Ward TL, McKinlay CE, et al,. Rethinking "enterotypes". Cell Host Microbe 2014; 16: 433-7.
31. Hooper LV, Littman DR, Macpherson AJ,. Interactions between the microbiota and the immune system. Science 2012; 336: 1268-73.
32. Cotter PD, Stanton C, Ross RP, Hill C,. The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing. Discov Med 2012; 70: 193-9.
33. De Filippo C, Cavalieri D, Di Paola M, et al,. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-6.
34. Clarke SF, Murphy EF, O'Sullivan O, et al,. Exercise and associated dietary extremes impact on gu t microbial diversity. Gut 2014; 63: 1913-20.
35. Hamaker BR, Tuncil YE,. A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota. J Mol Biol 2014; 426: 3838-50.
36. Lattimer JM, Haub MD,. Effects of dietary fiber and its components on metabolic health. Nutrients 2010; 2: 1266-89.
37. Derrien M, van Hylckama Vlieg JE,. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol 2015; pii: S0966-842X(15)00056-6. doi: 10.1016/j.tim.2015.03.002. [Epub ahead of print].
38. de Moreno LeBlanc A, LeBlanc JG,. Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World J Gastroenterol 2014; 20: 16518-28.
39. McFarland LV,. Use of probiotics to correct dysbiosis of normal microbiota following disease or disruptive events: a systematic review. BMJ Open 2014; 4: e005047.
40. Fry SC,. Primary cell wall metabolism: tracking the careers of wall polymers in living plant cells. New Phytol 2004; 161: 641-75.
41. Chassard C, Lacroix C,. Carbohydrates and the human gut microbiota. Curr Opin Clin Nutr Metab Care 2013; 16: 453-60.
42. Macfarlane GT, Gibson GR,. Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine. In:, Mackie RI, White BA, eds. Ecology and Physiology of Gastrointestinal Microbes Vol 1: Gastrointestinal Fermentations and Ecosystems. New York: Chapman & Hall, 1996; 269-318.
43. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA,. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 2008; 6: 121-31.
44. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ,. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19.
45. Scott KP, Duncan SH, Flint HJ,. Dietary fibre and the gut microbiota. Nutr Bull 2008; 33: 201-11.
46. Duncan SH, Louis P, Thomson JM, Flint HJ,. The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 2009; 11: 2112-22.
47. Vinolo MAR, Rodrigues HG, Nachbar RT, Curi R,. Regulation of inflammation by short chain fatty acids. Nutrients 2011; 3: 858-76.
48. Sengupta S, Muir JG, Gibson PR,. Does butyrate protect from colorectal cancer? J Gastroenterol Hepatol 2006; 21: 209-18.
49. Donohoe DR, Holley D, Collins LB, et al,. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov 2014; 4: 1387-97.
50. Belcheva A, Irrazabal T, Robertson SJ, et al,. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell 2001; 158: 288-99.
51. Bultman SJ, Jobin C,. Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite? Cell Host Microbe 2014; 16: 143-5.
52. Yatsunenko T, Rey FE, Manary MJ, et al,. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-7.
53. Lin A, Bik EM, Costello EK, et al,. Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS ONE 2013; 8: e53838.
54. Ou J, Carbonero F, Zoetendal EG, et al,. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013; 98: 111-20.
55. Wu GD, Chen J, Hoffmann C, et al,. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
56. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI,. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Trans Med 2009; 1: 6ra14.
57. -/- mice. Nature 2012; 487: 104-8.
58. Martinez-Medina M, Denizot J, Dreux N, et al,. Western diet induces dysbiosis with increased E. coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 2014; 63: 116-24.
59. David LA, Maurice CF, Carmody RN, et al,. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-63.
60. Claesson MJ, Jeffery IB, Conde S, et al,. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488: 178-84.
61. Cotillard A, Kennedy SP, Kong LC, et al,. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500: 585-8.
62. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE,. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007; 73: 1073-8.
63. Brinkworth GD, Noakes M, Clifton PM, Bird AR,. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Brit J Nutr 2009; 101: 1493-502.
64. Russell WR, Gratz SW, Duncan SH, et al,. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 2011; 93: 1062-72.
65. Barcenilla A, Pryde SE, Martin JC, et al,. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 2000; 66: 1654-61.
66. Staudacher H, Lomer MCE, Anderson J, et al,. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012; 142: 1510-8.
67. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG,. Diets that differ in their FODMAP content alter the colonic luminal microenvironment Gut 2015; 64: 93-100.
68. Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M,. Levine partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis 2014; 20: 1353-60.
69. Zachos M, Tondeur M, Griffiths AM,. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007; CD000542.
70. D'Argenio V, Precone V, Casaburi G, et al., An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am J Gastroenterol 2013; 108: 851-2
71. Gerasimidis K, Bertz M, Hanske L, et al,. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn's disease during enteral nutrition. Inflamm Bowel Dis 2014; 20: 861-71.
72. Cohen SA, Gold BD, Oliva S, et al,. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2014; 59: 516-21.
73. Darfeuille-Michaud A, Boudeau J, Bulois P, et al,. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-21.
74. Martin HM, Campbell BJ, Hart CA, et al,. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127: 80-93.
75. Negroni A, Costanzo M, Vitali R, et al,. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 913-24.
76. Schwiertz A, Jacobi M, Frick JS, Richter M, Rusch K, Köhler H,. Microbiota in pediatric inflammatory bowel disease. J Pediatr 2010; 157: 240-4.
77. Macfarlane S, Macfarlane GT, Cummings JH,. Review article: prebiotics in the gastrointestinal tract. Aliment Pharmacol Ther 2006; 24: 701-14.
78. Roberfroid M,. Prebiotics: the concept revisited. J Nutrition 2007; 137 (3 Suppl. 2): 830S-7S.
79. Gibson GR, Beatty ER, Wang X, Cummings JH,. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108: 975-82.
80. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R,. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 2011; 140: 1713-9.
81. Silvi S, Rumney CJ, Cresci A, Rowland IR,. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors. J Appl Microbiol 1999; 86: 521-30.
82. Kleessen B, Hartmann L, Blaut M,. Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora. Brit J Nutr 2001; 86: 291-300.
83. van den Abbeele P, Gérard P, Rabot S, et al,. Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol 2011; 13: 2667-80.
84. Djouzi Z, Andrieux C,. Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora. Brit J Nutr 1997; 78: 313-24.
85. Costabile A, Klinder A, Fava F, et al,. Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Brit J Nutr 2008; 99: 110-20.
86. Buddington RK, Williams CH, Chen SC, Witherly SA,. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 1996; 63: 709-16.
87. Salminen S, Salminen E,. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand J Gastroenterol (Suppl) 1997; 222: 45-8.
88. Tuohy KM, Ziemer CJ, Klinder A, Knöbel Y, Pool-Zobel BL, Gibson GR,. A human volunteer study to determine the prebiotic effects of lactulose powder on human colonic microbiota. Microb Ecol Health Dis 2002; 14: 165-73.
89. Costabile A, Kolida S, Klinder A, et al,. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Brit J Nutr 2010; 104: 1007-17.
90. Kleessen B, Schwarz S, Boehm A, et al,. Jerusalem artichoke and chicory inulin in bakery products affect faecal microbiota of healthy volunteers. Brit J Nutr 2007; 98: 540-9.
91. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P,. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Brit J Nutr 2009; 101: 541-50.
92. Davis LMG, Martínez I, Walter J, Goin C, Hutkins RW,. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS ONE 2011; 6: e25200.
93. Joossens M, Huys G, van Steen K, et al,. High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two Bifidobacterial species after inulin-type prebiotic intake. FEMS Microbiol Ecol 2011; 75: 343-9.
94. Kleessen B, Sykura B, Zunft HJ, Blaut M,. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997; 65: 1397-402.
95. Walker AW, Duncan SH, Leitch ECM, Child MW, Flint HJ,. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 2005; 71: 3692-700.
96. Flint HJ, Scott KP, Louis P, Duncan SH,. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012; 9: 577-89.
97. Milani C, Lugli GA, Turroni F, et al,. Evaluation of bifidobacterial community composition in the human gut by means of a targeted amplicon sequencing (ITS) protocol. FEMS Microbiol Ecol 2014; 90: 493-503.
98. Hallert C, Kaldma M, Petersson BG,. Ispaghula husk may relieve gastrointestinal symptoms in ulcerative colitis in remission. Scand J Gastroenterol 1991; 26: 747-50.
99. Kanauchi O, Mitsuyama K, Homma T, et al,. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int J Mol Med 2003; 12: 701-4.
100. Hanai H, Kanauchi O, Mitsuyama K, et al,. Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med 2004; 13: 643-7.
101. Hafer A, Kramer S, Duncker S, Kruger M, Manns MP, Bischoff SC,. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. BMC Gastroenterol 2007; 7: 36.
102. Benjamin JL, Hedin CR, Koutsoumpas A, et al,. Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. Gut 2011; 60: 923-9.
103. Joossens M, de Preter V, Ballet V, Verbeke K, Rutgeerts P, Vermeire S,. Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial. Gut 2012; 61: 958.
104. de Preter V, Joossens M, Ballet V, et al,. Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn's disease patients: a double-blinded randomized controlled trial. Clin Trans Gastroenterol 2013; 4: e30.
105. Englyst HN, Trowell H, Southgate DA, Cummings JH,. Dietary fiber and resistant starch. Am J Clin Nutr 1987; 46: 873-4.
106. Sajilata MG, Singhal RS, Kulkarni PR,. Resistant starch-a review. Compr Rev Food Sci Food Saf 2006; 5: 1-17.
107. Conlon MA, Kerr CA, McSweeney CS, et al,. Resistant starches protect against colonic DNA damage and alter microbiota and gene expression in rats fed a Western diet. J Nutr 2012; 142: 832-40.
108. Kleessen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M,. Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. J Animal Sci 1997; 75: 2453-62.
109. Wang X, Brown IL, Khaled D, Mahoney MC, Evans AJ, Conway PL,. Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules. J Appl Microbiol 2002; 93: 390-7.
110. Le Blay G, Michel C, Blottiere HM, Cherbut C,. Enhancement of butyrate production in the rat caecocolonic tract by long-term ingestion of resistant potato starch. Brit J Nutr 1999; 82: 419-26.
111. Martin LJM, Dumon HJW, Champ MMJ,. Production of short-chain fatty acids from resistant starch in a pig model. J Sci Food Agr 1998; 77: 71-80.
112. Haenen D, Zhang J, Souza da Silva C, et al,. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr 2013; 143: 274-83.
113. Abell GCJ, Cooke CM, Bennett CN, Conlon MA, McOrist AL,. Phylotypes related to Ruminococcus bromii are abundant in the large bowel of humans and increase in response to a diet high in resistant starch. FEMS Microbiol Ecol 2008; 66: 505-15.
114. Jenkins DJ, Vuksan V, Kendall CW, et al,. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr 1998; 17: 609-16.
115. Martinez I, Kim J, Duffy PR, Schlegel VL, Walter J,. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE 2010; 5: e15046.
116. Schwiertz A, Lehmann U, Jacobasch G, Blaut M,. Influence of resistant starch on the SCFA production and cell counts of butyrate-producing Eubacterium spp. in the human intestine. J Appl Microbiol 2002; 93: 157-62.
117. Leitch ECM, Walker AW, Duncan SH, Holtrop G, Flint HJ,. Selective colonization of insoluble substrates by human faecal bacteria. Environ Microbiol 2007; 9: 667-79.
118. Ze XL, Duncan SH, Louis P, Flint HJ,. Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 2012; 6: 1535-43.
119. Roberts CL, Keita AV, Duncan SH, et al,. Translocation of Crohn's disease Escherichia coli across M-cells: contrasting effects of soluble plant fibres and emulsifiers. Gut 2010; 59: 1331-9.
120. Roberts CL, Keita AV, Parsons BN, et al,. Soluble plantain fibre blocks adhesion and M-cell translocation of intestinal pathogens. J Nutr Biochem 2013; 24: 97-103.
121. Parsons BN, Wigley P, Simpson HL, et al,. Dietary supplementation with soluble plantain non-starch polysaccharides inhibits intestinal invasion of Salmonella Typhimurium in the chicken. PLoS ONE 2014; 9: e87658.
122. Backman RV,. The effects of plantain non-starch polysaccharide upon the gut bacteria. PhD Thesis, University of Aberdeen, UK, 2009.
123. D'Souza S, Levy E, Mack D, et al,. Dietary patterns and risk for Crohn's disease in children. Inflamm Bowel Dis 2008; 14: 367-73.
124. Ananthakrishnan AN, Khalili H, Konijeti GG, et al,. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013; 145: 970-7.
125. Murillo G, Mehta RG,. Cruciferous vegetables and cancer prevention. Nutr Cancer 2001; 41: 17-28.